[Biology of von Willebrand factor]

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Context:

• Von Willebrand factor (VWF) is a large glycoprotein essential for primary hemostasis.
• VWF mediates platelet adhesion to the subendothelium and platelet aggregation.
• VWF exists as multimers, with larger forms exhibiting enhanced function.

Purpose:

• To elucidate the role of VWF in hemostasis.
• To describe the regulatory function of ADAMTS13 on VWF multimer size.
• To explain the pathological consequences of dysregulated VWF activity.

Summary:

• VWF, synthesized by megakaryocytes and endothelial cells, functions as a molecular bridge via its interaction with platelet glycoprotein Ib.
• Platelet adhesion and aggregation are enhanced by VWF immobilization and high shear rates, with larger VWF multimers being more effective.
• ADAMTS13 protease critically regulates VWF multimer size in circulation, limiting it to approximately 15 x 10^6 Da.
• Optimal ADAMTS13 activity is observed under high shear conditions, coinciding with enhanced VWF function.
• A deficiency in ADAMTS13 activity can lead to the formation of VWF-rich platelet aggregates, causing thrombotic thrombocytopenic purpura.

Impact:

• Understanding VWF and ADAMTS13 regulation is key to comprehending hemostasis and thrombosis.
• This knowledge aids in diagnosing and potentially treating VWF-related bleeding disorders and thrombotic microangiopathies.
• Highlights the critical role of ADAMTS13 as a physiological regulator of platelet function.